These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10539653)

  • 1. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 1999 Jul; Suppl():14-5. PubMed ID: 10539653
    [No Abstract]   [Full Text] [Related]  

  • 2. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 2000 Aug; 32(8 Suppl):40-1. PubMed ID: 11183960
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and professional reference guides. Cut-off and toxicity levels for drugs-of-abuse testing.
    Williams RA
    MLO Med Lab Obs; 2001 Aug; 33(8 Suppl):16-7. PubMed ID: 11571830
    [No Abstract]   [Full Text] [Related]  

  • 4. The testing of urine specimens for drugs of abuse: background information.
    Cohen MR
    Hosp Pharm; 1987 Apr; 22(4):367-72. PubMed ID: 10317883
    [No Abstract]   [Full Text] [Related]  

  • 5. The epidemiology of drug abuse: current issues. Indicators of drug abuse--urinalysis screening.
    Berkowitz A
    NIDA Res Monogr; 1977 Mar; (10):138-52. PubMed ID: 405596
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AACC issues guidelines on drug abuse, cholesterol testing.
    MLO Med Lab Obs; 1987 Sep; 19(9):23-4. PubMed ID: 10317954
    [No Abstract]   [Full Text] [Related]  

  • 8. The place of the clinical laboratory in drug abuse.
    Albites V
    Md State Med J; 1973 Sep; 22(9):92-3. PubMed ID: 4774194
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute reactions to drugs of abuse.
    Med Lett Drugs Ther; 1996 May; 38(974):43-6. PubMed ID: 8628181
    [No Abstract]   [Full Text] [Related]  

  • 10. Cut-off and toxicity levels for drugs-of-abuse testing.
    Baer DM
    MLO Med Lab Obs; 2004 Aug; 36(13 Suppl):10-1. PubMed ID: 15543813
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of drug abuse presenting as psychiatric illness.
    Bloodworth RC
    Psychiatr Hosp; 1982; 13(2):60-4. PubMed ID: 10317258
    [No Abstract]   [Full Text] [Related]  

  • 12. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 2003 Aug; 35(8 Suppl):8-9. PubMed ID: 12964303
    [No Abstract]   [Full Text] [Related]  

  • 13. Tests for drugs of abuse.
    Med Lett Drugs Ther; 2002 Aug; 44(1137):71-3. PubMed ID: 12205429
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory diagnosis of toluene-based inhalants abuse.
    Thiesen FV; Noto AR; Barros HM
    Clin Toxicol (Phila); 2007; 45(5):557-62. PubMed ID: 17503266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical values for drug levels.
    MLO Med Lab Obs; 1999 Jul; Suppl():11. PubMed ID: 10539650
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary adulterants and drugs-of-abuse testing.
    Dasgupta A
    MLO Med Lab Obs; 2003 Feb; 35(2):26-8, 30-1. PubMed ID: 12624874
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological evaluation of compounds for their physical dependence potential and abuse liability. IX. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc. (1985).
    Jacobson AE
    NIDA Res Monogr; 1986; 67():385-98. PubMed ID: 3092095
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute toxic effects of drug abuse: diagnosis and treatment.
    J Fla Med Assoc; 1971 Apr; 58(4):41-2. PubMed ID: 5549095
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug abuse.
    Wolaver JH
    J Tenn Med Assoc; 1969 Jul; 62(7):612-5. PubMed ID: 5795948
    [No Abstract]   [Full Text] [Related]  

  • 20. Substance abuse programs grow steadily, while drug testing business may diminish.
    Richman D
    Mod Healthc; 1987 Jul; 17(14):94. PubMed ID: 10317918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.